Price
CHART BY
Frequently asked questions
What is Cresco Labs's market capitalization?
The market capitalization of Cresco Labs is $298.05M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Cresco Labs?
Cresco Labs's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.334. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Cresco Labs's stock?
Currently, 9 analysts cover Cresco Labs's stock, with a consensus target price of $1.879. Analyst ratings provide insights into the stock's expected performance.
What is Cresco Labs's revenue over the trailing twelve months?
Over the trailing twelve months, Cresco Labs reported a revenue of $981.30M.
What is the EBITDA for Cresco Labs?
Cresco Labs's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $219.26M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Cresco Labs?
Cresco Labs has a free cash flow of $146.07M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Cresco Labs have, and what sector and industry does it belong to?
Cresco Labs employs approximately 2,900 people. It operates in the Consumer Staples sector, specifically within the Agricultural Commodities/Milling industry.
What is the free float of Cresco Labs's shares?
The free float of Cresco Labs is 332.65M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $298.05M
- EPS (TTM)
- -$0.334
- Free Float
- 332.65M
- Revenue (TTM)
- $981.30M
- EBITDA (TTM)
- $219.26M
- Free Cashflow (TTM)
- $146.07M
Pricing
- 1D span
- $0.604$0.622
- 52W span
- $0.526$2.046
Analyst Ratings
The price target is $1.879 and the stock is covered by 9 analysts.
Buy
8
Hold
1
Sell
0
Information
Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL.
- Employees
- 2,900
- Industries
- Agricultural Commodities/Milling
- Sector
- Consumer Staples
Identifier
- ISIN
- CA22587M1068
- Primary Ticker
- CL
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet